Hsbc Holdings PLC Tg Therapeutics, Inc. Put Options Transaction History

Hsbc Holdings PLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	BUY	$13.32 - $19.19 $66,600 - $95,950	5,000 New	5,000 $88,000
Q4 2023 Feb 12, 2024	BUY	$6.68 - $18.81 $6,680 - $18,810	1,000 New	1,000 $17,000
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $54,180 - $122,500	3,500 New	3,500 $86,000
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $41,610 - $54,300	1,000 Added 33.33%	4,000 $192,000
Q3 2020 Nov 12, 2020	SELL	$18.49 - $27.24 $129,429 - $190,680	-7,000 Reduced 70.0%	3,000 $80,000
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $35,600 - $87,360	4,000 Added 66.67%	10,000 $195,000
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $25,080 - $34,600	4,000 Added 200.0%	6,000 $52,000
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $8,039 - $16,079	2,000 New	2,000 $16,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.